Erythropoietin stimulates phosphorylation and activation of GATA-1 via the PI3-kinase/AKT signaling pathway

被引:147
作者
Zhao, W
Kitidis, C
Fleming, MD
Lodish, HF
Ghaffari, S [1 ]
机构
[1] Mt Sinai Sch Med, Dept Gene & Cell Med, Div Hematol Oncol, New York, NY 10029 USA
[2] Mt Sinai Sch Med, Dept Med, Div Hematol Oncol, New York, NY USA
[3] Whitehead Inst Biomed Res, Cambridge, England
[4] Harvard Univ, Sch Med, Childrens Hosp, Dept Pathol, Boston, MA USA
[5] MIT, Dept Biol, Cambridge, MA USA
关键词
D O I
10.1182/blood-2005-06-2516
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Erythropoietin (Epo) stimulation of its receptor's downstream signaling pathways and optimum function of GATA-1 transcription factor are both essential for normal erythroid cell development. Eporeceptor (EpoR) signaling and GATA-1 regulate proliferation, survival, differentiation, and maturation of erythroid cells. Whether any signal that is generated by EpoR targets GATA-1 or affects GATA-1 transcriptional activity is not known. Here, we demonstrate that stimulation of EpoR results in phosphorylation of GATA-1 at serine 310 (S310) in primary fetal liver erythroid progenitors and in cultured erythroid cells. We show that phosphorylation of GATA-1 is important for Epo-induced maturation of fetal liver erythroid progenitor cells. The P13-kinase/AKT signaling pathway is identified as a mediator of Epo-induced phosphorylation of GATA-1. AKT serine threonine kinase phosphorylates GATA-1S310 in vitro and in erythroid cells and enhances GATA-1 transcriptional activity. These data demonstrate that EpoR signaling phosphorylates GATA-1 and modulates its activity via the P13-kinase/AKT signaling pathway.
引用
收藏
页码:907 / 915
页数:9
相关论文
共 72 条
[31]   Phosphatidylinositol 3-kinase is involved in the protection of primary cultured human erythroid precursor cells from apoptosis [J].
Haseyama, Y ;
Sawada, K ;
Oda, A ;
Koizumi, K ;
Takano, H ;
Tarumi, T ;
Nishio, M ;
Handa, M ;
Ikeda, Y ;
Koike, T .
BLOOD, 1999, 94 (05) :1568-1577
[32]   DNA damage-induced cell-cycle arrest of hematopoietic cells is overridden by activation of the PI-3 kinase/Akt signaling pathway [J].
Henry, MK ;
Lynch, JT ;
Eapen, AK ;
Quelle, FW .
BLOOD, 2001, 98 (03) :834-841
[33]   Functional p85α gene is required for normal murine fetal erythropoiesis [J].
Huddleston, H ;
Tan, BL ;
Yang, FC ;
White, H ;
Wenning, MJ ;
Orazi, A ;
Yoder, MC ;
Kapur, R ;
Ingram, DA .
BLOOD, 2003, 102 (01) :142-145
[34]  
Hung HL, 1999, MOL CELL BIOL, V19, P3496
[35]   A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera [J].
James, C ;
Ugo, V ;
Le Couédic, JP ;
Staerk, J ;
Delhommeau, F ;
Lacout, C ;
Garçon, L ;
Raslova, H ;
Berger, R ;
Bennaceur-Griscelli, A ;
Villeval, JL ;
Constantinescu, SN ;
Casadevall, N ;
Vainchenker, W .
NATURE, 2005, 434 (7037) :1144-1148
[36]   A novel mechanism of cooperation between c-Kit and erythropoietin receptor - Stem cell factor induces the expression of Stat5 and erythropoietin receptor, resulting in efficient proliferation and survival by erythropoietin [J].
Kapur, R ;
Zhang, L .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (02) :1099-1106
[37]   A member of Forkhead family transcription factor, FKHRL1, is one of the downstream molecules of phosphatidylinositol 3-kinase-Akt activation pathway in erythropoietin signal transduction [J].
Kashii, Y ;
Uchida, M ;
Kirito, K ;
Tanaka, M ;
Nishijima, K ;
Toshima, M ;
Ando, T ;
Koizumi, F ;
Endoh, T ;
Sawada, K ;
Momoi, M ;
Miura, Y ;
Ozawa, K ;
Komatsu, N .
BLOOD, 2000, 96 (03) :941-949
[38]   Thrombopoietin rescues in vitro erythroid colony formation from mouse embryos lacking the erythropoietin receptor [J].
Kieran, MW ;
Perkins, AC ;
Orkin, SH ;
Zon, LI .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (17) :9126-9131
[39]   Identification of a novel pathway important for proliferation and differentiation of primary erythroid progenitors [J].
Klingmuller, U ;
Wu, H ;
Hsiao, JG ;
Toker, A ;
Duckworth, BC ;
Cantley, LC ;
Lodish, HF .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (07) :3016-3021
[40]   A gain-of-function mutation of JAK2 in myeloproliferative disorders [J].
Kralovics, R ;
Passamonti, F ;
Buser, AS ;
Teo, S ;
Tiedt, R ;
Passweg, JR ;
Tichelli, A ;
Cazzola, M ;
Skoda, RC .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (17) :1779-1790